BFC Planning’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9 Hold
8
– – ﹤0.01% 3449
2026
Q2
$25 Buy
+8
New +$25 ﹤0.01% 3391

Other funds holding CODX

BFC Planning's CODX Position: Q3 2026 in Review

BFC Planning held its Co-Diagnostics (CODX) position steady in Q3 2026 at 8 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #3449.

BFC Planning first reported a position in CODX in Q2 2026 and has held it in 2 quarters since. The position peaked at $25 in Q2 2026. 20 funds tracked by Wall St. Rank hold CODX as of Q3 2026.

  • BFC Planning held 8 shares of Co-Diagnostics worth $9 as of Q3 2026.
  • BFC Planning left its Co-Diagnostics share count unchanged in Q3 2026.
  • Co-Diagnostics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3449 holding.
  • BFC Planning first reported a position in Co-Diagnostics in Q2 2026 and has held it in 2 quarters since.
  • BFC Planning's Co-Diagnostics position peaked at $25 in Q2 2026.
  • 20 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.